Antifungal effects of Lactobacillus rhamnosus to Candida tropicalis: An in vitro study

Paper Details

Research Paper 12/05/2024
Views (105) Download (19)
current_issue_feature_image
publication_file

Antifungal effects of Lactobacillus rhamnosus to Candida tropicalis: An in vitro study

Mulan Shanti M. Sunico, Rana Francine R. Santonil, Yla Juliana Q. Sinacsi, Yeshalureen O. Sy, Stephanie Kate C. Undajon, Nathalle A. Valenzona, Kylene Chardonnay M. Villena, Laarni Hannah C. Lacorte, Melissa Mondoy
Int. J. Biosci.24( 5), 211-219, May 2024.
Certificate: IJB 2024 [Generate Certificate]

Abstract

Candida is known to cause various diseases due to its ability to colonize mucosal surfaces and other sites of the body. Lactobacillus rhamnosus, on the other hand, creates an antagonistic pattern to reduce inflammation against fungal organisms by inducing metabolic changes in the fungus. Through this, the study aimed to investigate and understand the inhibitory effects of Lactobacillus rhamnosus to Candida tropicalis and ultimately correlate its effect in comparison to nystatin. Pure cultures of L. rhamnosus and C. tropicalis were used in the experimentation.  In the study, it was shown that both species exhibit co-aggregation, thus had potential in competitive exclusion. To explore the inhibitory effect of L. rhamnosus, agar well diffusion assay was utilized to visualize inhibition zones of each concentration: 103, 105, 107, and 109. In the results of this assay, L. rhamnosus has shown inhibitory effects most optimally in 109 CFU/mL concentration. In comparison to nystatin, 107 and 109 CFU/mL had shown same/greater inhibition zones. Furthermore, this test exemplified that higher concentrations tend to have greater inhibition zones. To further examine the effect, agar overlay interference test was utilized. This was to show bacterial growth inhibition. In the results of this test, it was shown that all concentrations except 103 CFU/mL had shown inhibition in terms colony size. In brief, Lactobacillus rhamnosus exhibited antifungal activity against Candida tropicalis and has statistically exemplified the same inhibitory effect to nystatin. Moreover, the results reconfirms that the inhibitory effect of L. rhamnosus is dependent on its concentration.

VIEWS 47

Arastehfar A, Hilmioğlu-Polat S, Daneshnia F, Hafez A, Salehi M, Polat F, Yaşar M, Arslan N, Hoşbul T, Ünal N, Metin D, Gürcan S, Birinci A, Koç A, Pan W, Ilkit M, Perlin DS, Lass-Flörl C. 2020. Recent increase in the prevalence of fluconazole-non-susceptible Candida tropicalis blood isolates in Turkey: Clinical implication of azole-non-susceptible and fluconazole tolerant phenotypes and genotyping. Frontiers in Microbiology 11. https://doi.org/10.3389/fmicb.2020.587278

Deorukhkar S, Saini S, Matthew S. 2014. Virulence factor contributing to the pathogenicity of Candida tropicalis and its antifungal susceptibility profile. International Journal of Microbiology 2014, 456878. https://doi.org/10.1155/2014/456878

Jørgensen MR, Rikvold PT, Lichtenberg, M, Jensen PØ, Kragelund C, Twetman S. 2020. Lactobacillus rhamnosus strains of oral and vaginal origin show strong antifungal activity in vitro. Journal of Oral Microbiology 12. https://doi.org/10.1080/20002297.2020.1832832

Mathur H, Beresford TP, Cotter PD. 2020. Health benefits of lactic acid bacteria (LAB) fermentates. Nutrients 12(6). https://doi.org/10.3390/nu12061679

Salari S, Almani P. 2020. Antifungal effects of Lactobacillus acidophilus and Lactobacillus plantarum against different oral Candida species isolated from HIV/ AIDS patients: an in vitro study. J Oral Microbiology 12(1). https://doi.org/10.1080/20002297.2020.1769386

Turner S, Butler G. 2014. The Candida pathogenic species complex. Cold Spring Harb Perspect Med 4(9), a019778. DOI: 10.1101/cshperspect.a019778

Vázquez-Muñoz R, Dongari-Bagtzoglou A. 2021. Anticandidal activities by Lactobacillus species: An update on mechanisms of action. Frontiers in Oral Health 2. https://doi.org/10.3389/froh.2021.689382

Zuza-Alves DL, Silva-Rocha WP, Chavez GM. 2017. An update on Candida tropicalis based on basic and clinical approaches. Frontiers in Microbiology 8. https://doi.org/10.3389/fmicb.2017.01927